<?xml version="1.0" encoding="utf-8" ?><rss version="2.0"><channel><title>Bing: Path Pushing Algorithm in Distributed System</title><link>http://www.bing.com:80/search?q=Path+Pushing+Algorithm+in+Distributed+System</link><description>Search results</description><image><url>http://www.bing.com:80/s/a/rsslogo.gif</url><title>Path Pushing Algorithm in Distributed System</title><link>http://www.bing.com:80/search?q=Path+Pushing+Algorithm+in+Distributed+System</link></image><copyright>Copyright © 2026 Microsoft. All rights reserved. These XML results may not be used, reproduced or transmitted in any manner or for any purpose other than rendering Bing results within an RSS aggregator for your personal, non-commercial use. Any other use of these results requires express written permission from Microsoft Corporation. By accessing this web page or using these results in any manner whatsoever, you agree to be bound by the foregoing restrictions.</copyright><item><title>Market Wire News on X: "$PATH - UiPath Announces Upcoming ...</title><link>https://x.com/marketwirenews/status/2092231584657064076</link><description>$ PATH - UiPath Announces Upcoming Investor Day UiPath (NYSE: PATH), a leader in business orchestration and automation, today announced it will host an Investor Day on Tuesday, September 22, 2026, in Las Vegas starting at 11:30 am PT (2:30 pm ET). …</description><pubDate>Tue, 25 Aug 2026 13:38:00 GMT</pubDate></item><item><title>Nycole on X: "https://t.co/BzhGJvfB6i" / X</title><link>https://x.com/ny14co/status/2092187175660016010</link><description>GenLayer appears to be choosing the second path. ### The Real Signal Whether *Agent Tank* becomes a serious long-running show or remains a short experiment is almost secondary. The decision to frame it as a TV series already tells us how the team is thinking. They are no longer only asking: “How do we make the best adjudication protocol?”</description><pubDate>Tue, 25 Aug 2026 10:46:00 GMT</pubDate></item><item><title>HaxKai on X: "I said I wouldn’t let that person take up space ...</title><link>https://x.com/chartexpt/status/2092192517060194734</link><description>When #BITCOIN was around $62.5K, the chart was clearly showing the potential path toward $75.5K, yet these larpers were still calling for $44K and pushing toxic narratives instead of actually reading the structure. That’s the difference between technical analysis and toxic advice.</description><pubDate>Tue, 25 Aug 2026 10:32:00 GMT</pubDate></item><item><title>UnlimitedApathy on X: "@lachancenaomi27 What does “Zionist ...</title><link>https://x.com/UnlimitedApathE/status/2092173232933654586</link><description>@lachancenaomi27 What does “Zionist brand” mean here? Like it’s an isreali brand? Or it’s a random dressmaker who is a Zionist? Bc I’ll be honest it would never occur to me to talk politics with whoever I’m buying a dress from.</description><pubDate>Tue, 25 Aug 2026 10:10:00 GMT</pubDate></item><item><title>Loriel.AI on X: "The series works because the bowl stays ...</title><link>https://x.com/ou_zhen599/status/2092155004761285113</link><description>The series works because the bowl stays identical while the typography keeps changing its attitude. That gives you campaign variety without losing the product system. same pho bowl repeated across a 2x2 grid with changing type direction You see consistency first, then</description><pubDate>Tue, 25 Aug 2026 08:44:00 GMT</pubDate></item><item><title>Maryam Rajavi on X: "Iran’s national currency is in a ...</title><link>https://x.com/Maryam_Rajavi/status/2092189168763814285</link><description>Iran’s national currency is in a freefall: $1 USD has hit 202,500 Tomans—up from 95,800 Tomans just a year ago. In 12 months, the public has lost over half their purchasing power. According to official state figures (which severely undercount reality, food inflation surged to</description><pubDate>Tue, 25 Aug 2026 10:32:00 GMT</pubDate></item><item><title>ClearPath on X: "$QURE Sector context and the risk ledger. On ...</title><link>https://x.com/ClearPath100/status/2092183983970713984</link><description>$ QURE Sector context and the risk ledger. On August 19, Merck and Moderna reported that intismeran autogene plus Keytruda met both recurrence-free survival and distant metastasis-free survival endpoints in Phase 3 resected melanoma, at a pre-planned interim analysis. It is the first individualized neoantigen therapy to win a Phase 3. $ MRNA roughly doubled that session; $ MRK gained about 12% ...</description><pubDate>Tue, 25 Aug 2026 10:46:00 GMT</pubDate></item></channel></rss>